Nom du produit:3-(1-bromo-8-chloroimidazo[1,5-a]pyrazin-3-yl)cyclobutan-1-one
IUPAC Name:3-{1-bromo-8-chloroimidazo[1,5-a]pyrazin-3-yl}cyclobutan-1-one
- CAS：936901-73-4
- Formule moléculaire：C10H7BrClN3O
- Pureté：95%
- Numéro de catalogue：CM168482
- Poids moléculaire：300.54
Pour une utilisation en R&D uniquement..
Détails du produit
- N° CAS:936901-73-4
- Formule moléculaire:C10H7BrClN3O
- Point de fusion:-
- Code SMILES:O=C1CC(C2=NC(Br)=C3C(Cl)=NC=CN32)C1
- Densité:
- Numéro de catalogue:CM168482
- Poids moléculaire:300.54
- Point d'ébullition:
- N° Mdl:MFCD25542109
- Stockage:
Category Infos
- Cyclobutanes
- The molecular structure of cyclobutane has four carbon atoms, and its four carbon atoms are not in the same plane, which is the folded conformation of cyclobutane. Cyclobutane itself is not of commercial or biological interest, but more complex derivatives are important in biology and biotechnology. Currently, nine FDA-approved drugs contain the cyclobutane structure. From the perspective of therapeutic areas, cyclobutyl drugs are mainly distributed in popular areas such as tumors, neurological diseases, infectious diseases, endocrine and metabolic diseases.
- Imidazopyrazines
- In addition to the nitrogen-based heterocycles presented so far, a number of others nitrogen-based scaffolds have also been reported as promising agents for GBM treatment, including pyrazolo-triazole, imidazotetrazine, piperidine, purine, imidazopyrazine, pyrazole, triazole among others.
Recherche 
+86 21 5895 0110 
